Literature DB >> 19881512

Hepatitis: new hope for difficult cases of autoimmune hepatitis.

Ugur Halac1, Fernando Alvarez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19881512     DOI： 10.1038/nrgastro.2009.179

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  Diagnosis and treatment of autoimmune hepatitis.

Authors:  Albert J Czaja; Deborah K Freese
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

2.  Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.

Authors:  Nazira Chatur; Alnoor Ramji; Vincent G Bain; Mang M Ma; Paul J Marotta; Cameron N Ghent; Leslie B Lilly; E Jenny Heathcote; Marc Deschenes; Samuel S Lee; Urs P Steinbrecher; Eric M Yoshida
Journal:  Liver Int       Date:  2005-08       Impact factor: 5.828

3.  Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis.

Authors:  D Debray; G Maggiore; J P Girardet; E Mallet; O Bernard
Journal:  J Pediatr       Date:  1999-07       Impact factor: 4.406

4.  A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

Authors:  T van Gelder; L B Hilbrands; Y Vanrenterghem; W Weimar; J W de Fijter; J P Squifflet; R J Hené; G A Verpooten; M T Navarro; M D Hale; A J Nicholls
Journal:  Transplantation       Date:  1999-07-27       Impact factor: 4.939

5.  A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

Authors:  J Kobashigawa; L Miller; D Renlund; R Mentzer; E Alderman; R Bourge; M Costanzo; H Eisen; G Dureau; R Ratkovec; M Hummel; D Ipe; J Johnson; A Keogh; R Mamelok; D Mancini; F Smart; H Valantine
Journal:  Transplantation       Date:  1998-08-27       Impact factor: 4.939

Review 6.  Current therapy for autoimmune hepatitis.

Authors:  Aldo J Montano Loza; Albert J Czaja
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2007-04

7.  Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

Authors:  P Halloran; T Mathew; S Tomlanovich; C Groth; L Hooftman; C Barker
Journal:  Transplantation       Date:  1997-01-15       Impact factor: 4.939

8.  Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up.

Authors:  Marion M Aw; Anil Dhawan; Marianne Samyn; Aikaterini Bargiota; Giorgina Mieli-Vergani
Journal:  J Hepatol       Date:  2009-04-09       Impact factor: 25.083

9.  RS-61443--a phase I clinical trial and pilot rescue study.

Authors:  H W Sollinger; M H Deierhoi; F O Belzer; A G Diethelm; R S Kauffman
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

10.  Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis.

Authors:  Bashar A Aqel; Victor Machicao; Barry Rosser; Raj Satyanarayana; Denise M Harnois; Rolland C Dickson
Journal:  J Clin Gastroenterol       Date:  2004-10       Impact factor: 3.062
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.